It should be noted that immunosuppressive therapy could make a significant contribution to decreasing the proliferative activity of Tregs in RA patients; nonetheless, we did not reveal any differences in the proliferation of CD4+ or CD8+ cells between the HDs and RA patients under any of the stimulation conditions (Figure 6). The gene discussed is CD4; the disease is rheumatoid arthritis.